Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Gynecologic Oncology
|
March 19, 2017
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Yvette W Jeske, Shamshad Ali, Sara A Byron, et al.
Lancet (London, England)
|
November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial
Janet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.
Gynecologic Oncology
|
December 4, 2012
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173
Robert L Coleman, Shamshad Ali, Charles F Levenback, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
Charles F Levenback, Shamshad Ali, Robert L Coleman, et al.
Gynecologic Oncology
|
April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol
William T Creasman, Shamshad Ali, David G Mutch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
D Scott McMeekin, David L Tritchler, David E Cohn, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 17, 2012
Uterine serous carcinoma: increased familial risk for lynch-associated malignancies
Summer B Dewdney, Nora T Kizer, Abegail A Andaya, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
Theodore M Brasky, Ashley S Felix, David E Cohn, et al.
Blood
|
January 12, 2026
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia
Janet L Kwiatkowski, Alexis A Thompson, Jennifer Schneiderman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Gynecologic Oncology
|
March 19, 2017
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Yvette W Jeske, Shamshad Ali, Sara A Byron, et al.
Lancet (London, England)
|
November 11, 2024
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial
Janet L Kwiatkowski, Mark C Walters, Suradej Hongeng, et al.
Gynecologic Oncology
|
December 4, 2012
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173
Robert L Coleman, Shamshad Ali, Charles F Levenback, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
Charles F Levenback, Shamshad Ali, Robert L Coleman, et al.
Gynecologic Oncology
|
April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol
William T Creasman, Shamshad Ali, David G Mutch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
D Scott McMeekin, David L Tritchler, David E Cohn, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 17, 2012
Uterine serous carcinoma: increased familial risk for lynch-associated malignancies
Summer B Dewdney, Nora T Kizer, Abegail A Andaya, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
Theodore M Brasky, Ashley S Felix, David E Cohn, et al.
Blood
|
January 12, 2026
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia
Janet L Kwiatkowski, Alexis A Thompson, Jennifer Schneiderman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Page
of 4